BR100 Increased By (0.1%)
BR30 Increased By (0.24%)
KSE100 Increased By (0.18%)
KSE30 Increased By (0.25%)
AGHA 6.55 Increased By ▲ 0.23 (3.64%)
BECO 4.42 Increased By ▲ 0.15 (3.51%)
BML 62.11 Decreased By ▼ -0.34 (-0.54%)
BOP 31.48 Increased By ▲ 0.25 (0.8%)
CNERGY 11.72 Increased By ▲ 0.13 (1.12%)
CSIL 6.09 Increased By ▲ 0.37 (6.47%)
FCCL 61.15 Decreased By ▼ -0.39 (-0.63%)
FFL 14.92 Decreased By ▼ -0.10 (-0.67%)
FNEL 1.25 Increased By ▲ 0.02 (1.63%)
KEL 6.26 No Change ▼ 0.00 (0%)
KOSM 5.67 Increased By ▲ 0.11 (1.98%)
LOTCHEM 24.65 Decreased By ▼ -0.03 (-0.12%)
MLCF 103.12 Decreased By ▼ -0.96 (-0.92%)
NBP 174.99 Decreased By ▼ -0.29 (-0.17%)
NCPL 53.19 Increased By ▲ 0.42 (0.8%)
NPL 54.67 Increased By ▲ 0.55 (1.02%)
OGDC 314.33 Increased By ▲ 0.94 (0.3%)
PACE 9.29 Increased By ▲ 0.09 (0.98%)
PAEL 35.58 Decreased By ▼ -0.22 (-0.61%)
PIBTL 13.63 Increased By ▲ 0.16 (1.19%)
PPL 222.75 Increased By ▲ 0.94 (0.42%)
PRL 80.49 Increased By ▲ 1.41 (1.78%)
PTC 47.10 Increased By ▲ 0.25 (0.53%)
SSGC 24.00 Increased By ▲ 0.13 (0.54%)
TBL 9.26 Decreased By ▼ -0.05 (-0.54%)
TELE 7.44 Increased By ▲ 0.05 (0.68%)
TPL 24.50 Decreased By ▼ -0.61 (-2.43%)
TPLP 12.85 Increased By ▲ 0.34 (2.72%)
TREET 26.14 Decreased By ▼ -0.11 (-0.42%)
TRG 53.80 Increased By ▲ 0.36 (0.67%)
World

AstraZeneca denounces 'me first' approach to Covid jabs

  • "Globally, it is fair to say we could and should have been better prepared for this pandemic," he added.
Published Updated
By

LONDON: The boss of British drugs giant AstraZeneca, which with Oxford University has produced a Covid vaccine, denounced Monday a "me first" approach by some countries to obtaining doses.

AstraZeneca chief executive Pascal Soriot, speaking at a virtual event for the Davos World Economic Forum, also attacked a lack of global preparation for the deadly coronavirus pandemic.

The arrival of ground-breaking Covid-19 vaccines could have been grounds for celebrating, "but it unfortunately wasn't because there was a little bit of 'me first' behaviour", Soriot said.

"Globally, it is fair to say we could and should have been better prepared for this pandemic," he added.

Soriot noted however that "things are changing and international collaboration is emerging" over the coronavirus that has claimed the lives of more than two million people.

"There are many good examples of tremendous public-private collaboration actually in many countries," he said.

Going forward, "the first thing to do is to invest in prevention and early detection and early treatment", Soriot added.

He noted that among the world's most industrialised countries, only three-percent of health expenditure is spent on prevention.

"Twenty percent of this 3.0 percent... is spent on immunisation and early detections of disease.

"So, essentially, we kind of tend to wait for people to become sick to try to address that, as opposed to early detecting (of) disease and preventing it."

Comments

Comments are closed for this article.